MS drug developer Kyverna Therapeutics files for $100 million IPO
Chunumunu Kyverna Therapeutics (KYTX), which is developing therapies for autoimmune disorders such as lupus and multiple sclerosis, has filed a ...
Tag: Therapeutics
Citigroup Upgrades Larimar Therapeutics to Buy, Predicts 284% Rise By Investing.com
© Reuters. NEW YORK - Citigroup revised its stance on Larimar Therapeutics (NASDAQ: LRMR), upgrading the stock from Neutral to ...
OS Therapeutics, developer of bone cancer drugs, files for $10 million initial public offering (pending: OSTX)
2d illustrations and photos OS Therapeutics (OSTX), which is developing therapies to treat bone cancer, has applied to raise $10 ...
Recommended.
